A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Rod S Taylor, Alain Amstutz et al.|EClinicalMedicine|2023Cited by 60
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ|2024Cited by 45
Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping reviewAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|Journal of Clinical Epidemiology|2023Cited by 30
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ|2024Cited by 28
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATEAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ Open|2022Cited by 21